Andrew Kenneth William Powell - 08 Nov 2022 Form 4 Insider Report for Aclaris Therapeutics, Inc. (ACRS)

Role
Director
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
Issuer symbol
ACRS
Transactions as of
08 Nov 2022
Net transactions value
$0
Form type
4
Filing time
20 Jan 2023, 16:08:55 UTC
Previous filing
13 Jun 2022
Next filing
05 Jun 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACRS Common Stock Gift $0 -4,000 -29% $0.000000 9,856 08 Nov 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.